Collagen II hydrogel-mediated sustained delivery of lacosamide attenuates cartilage degeneration and pain in osteoarthritis

作者
Chaopeng He,Guiwu Huang,Lida Moradi,Jingwei Bi,Xinyu Yang,Xin Liu,Xudong Cui,Arya Varthi,Daniel Howard Wiznia,Stephen G. Waxman,Wenyu Fu,Chuan-Ju Liu
出处
期刊:Bioactive Materials [Elsevier BV]
卷期号:61: 640-656
标识
DOI:10.1016/j.bioactmat.2026.02.045
摘要

Osteoarthritis (OA) lacks effective disease-modifying therapies. Nav1.7 has recently been identified as a regulator of both chondrocyte metabolism and pain, establishing it as a dual-acting therapeutic target in OA. This study evaluated lacosamide (LCM) as a disease-modifying candidate and developed a cartilage-targeted delivery strategy to enhance its translational potential. Sodium channel inhibitors (carbamazepine, oxcarbazepine, and LCM) were evaluated in primary human OA chondrocytes, cartilage explants, and a murine DMM model with systemic or intra-articular administration. Pain behavior was assessed by von Frey and open-field testing. A collagen II–based thermoresponsive hydrogel was developed for sustained intra-articular delivery, and outcomes were assessed by histology, immunohistochemistry, ELISA, and gene expression analyses. LCM was the most potent inhibitor in suppressing IL-1β–induced catabolism and promoting anabolism in human chondrocytes, showing greater efficacy at lower concentrations than carbamazepine or oxcarbazepine. Systemic LCM reduced cartilage degeneration and pain in murine OA and outperformed carbamazepine at equivalent doses, while intra-articular administration achieved superior protection and analgesia at one-tenth the dose. Mechanistically, LCM increased HSP70 and midkine secretion to drive anabolic and anti-catabolic responses. Sustained delivery via a collagen II-based hydrogel prolonged joint retention and enhanced therapeutic durability. Together with its clinical efficacy in Nav1.7 mutation–related neuropathy, these findings underscore LCM's translational potential as a dual-acting disease-modifying therapy for OA. LCM is a dual-acting Nav1.7 inhibitor that alleviates pain and modifies OA progression. Collagen II–based intra-articular delivery enhances efficacy and supports clinical translation as a noninvasive, non-opioid disease-modifying therapy. • Lacosamide modulates chondrocyte metabolism through Nav1.7 inhibition. • Lacosamide outperforms carbamazepine in protecting cartilage and reducing OA pain. • Collagen II–based hydrogel enables sustained intra-articular LCM delivery. • Hydrogel-released LCM provides long-lasting structural and analgesic benefits in OA. • Combining Nav1.7 inhibition with biomaterial delivery offers a disease-modifying OA therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
Hui发布了新的文献求助10
2秒前
2秒前
CodeCraft的应助被vickylow采纳,获得10
2秒前
科研陈完成签到,获得积分10
3秒前
水天需发布了新的文献求助10
3秒前
3秒前
汉堡包的应助被godsky采纳,获得10
4秒前
4秒前
冬眠完成签到,获得积分10
4秒前
4秒前
天天快乐的应助被ZZ采纳,获得10
5秒前
6秒前
搜集达人的应助被阿三采纳,获得10
7秒前
Nole的应助被机长采纳,获得10
7秒前
牧百川发布了新的文献求助20
7秒前
阔达冷荷发布了新的文献求助10
7秒前
Jackking完成签到,获得积分10
8秒前
8秒前
乐乐的应助被WN采纳,获得10
9秒前
青雾雨完成签到,获得积分10
10秒前
10秒前
lzt发布了新的文献求助10
10秒前
zxy发布了新的文献求助10
11秒前
11秒前
11秒前
追逐123完成签到,获得积分10
12秒前
renn发布了新的文献求助10
12秒前
xujiahao发布了新的文献求助10
12秒前
水天需发布了新的文献求助10
13秒前
鳗鱼不二发布了新的文献求助10
13秒前
14秒前
123发布了新的文献求助10
14秒前
15秒前
小二郎的应助被Dugarrygana采纳,获得10
15秒前
15秒前
西红柿呀发布了新的文献求助20
16秒前
molihuakai的应助被GJoey采纳,获得10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183894
求助须知:如何正确求助?哪些是违规求助? 9573067
关于积分的说明 21829226
捐赠科研通 7780983
什么是DOI,文献DOI怎么找? 3434150
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480648